| Autor: |
Slaney CY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Luo P; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China., Kong FM; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong SAR, China.; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Guo L; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China., Zhang J; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. |
